Owners, management and financials
CVR: 38401572
Previous names: UV Clinical ApS
DKK 1,274,253
Gross profit
Net result: DKK -1,282,165
Ulstrup Invest ApS (15-19,99%), Canajo Invest ApS (25-33,32%)
1 more
CVR · view owners
Rolf Henrik Sprunk-Jansen
Board: Helge Holm-Larsen (chair) and 2 members
CVR · view management
Active
Founded 1 February 2017
CVR · view overview
3 employees
CVR · 2026
Owner registered: Ulstrup Invest ApS
CVR · 19/08/2026
View the full event history
UV Clinical A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UV Clinical ApS. The management consists of Rolf Henrik Sprunk-Jansen. The board consists of Helge Holm-Larsen (chair), Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen. The company is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 1,274,253 and a net result of DKK -1,282,165 compared with DKK -1,895,100 the year before. Equity in the 2025 report amounted to DKK 22,796,335.
Source: annual report 2025, Danish Business Authority
The financial health of UV Clinical A/S shows a concerning trajectory, with consistent losses over the past five years, culminating in a profit of -1,282,165 DKK in 2025. Gross profit has fluctuated, peaking at 2,235,490 DKK in 2023, but overall profitability remains elusive, indicating challenges in converting sales into profit. Despite a significant equity position of 22,796,335 DKK in 2025, the company's reliance on gross profit margins is a concern, particularly as it has not disclosed revenue figures. Established in 2017, UV Clinical A/S operates within the medical and dental instrument manufacturing sector, where it faces competitive pressures and must improve its financial performance to secure a stronger market position.
AI-generated summary · Generated 16/08/2026
Virksomhedens formål er at udvikle, kommercialisere og sælge desinfektion af venekatetre og entracheale katetre ved hjælp af UVC LED lys.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 1.3 mio. | -1.3 mio. | 33.8 mio. | 22.8 mio. | 3 | |
| 202401/01/2024 – 31/12/2024 | 392 t. | -1.9 mio. | 23 mio. | 20.1 mio. | 2 | |
| 202301/01/2023 – 31/12/2023 | 2.2 mio. | -417 t. | 11.2 mio. | 8.2 mio. | 2 | |
| 202201/01/2022 – 31/12/2022 | 151 t. | -269 t. | 2.4 mio. | 1.7 mio. | 1 | |
| 202101/01/2021 – 31/12/2021 | 33 t. | 2.2 mio. | 160 t. | 124 t. | 1 | |
| 202001/01/2020 – 31/12/2020 | -411 t. | -1.1 mio. | 305 t. | -2.1 mio. | 1 | |
| 201901/01/2019 – 31/12/2019 | -577 t. | -1.4 mio. | 1.2 mio. | -975 t. | 1 | |
| 201801/01/2018 – 31/12/2018 | 4 t. | -799 t. | 1.3 mio. | -584 t. | 1 | |
| 201701/02/2017 – 31/12/2017 | -376 t. | -1.1 mio. | 699 t. | 215 t. | 1 |
Compared to 309 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of UV Clinical A/S is 38401572.
UV Clinical A/S is owned by Ulstrup Invest ApS, Canajo Invest ApS and Holafa ApS.
The management of UV Clinical A/S consists of Rolf Henrik Sprunk-Jansen.
The board of UV Clinical A/S consists of Helge Holm-Larsen, Emilio de la Guardia Gascuñana and Rolf Henrik Sprunk-Jansen, with Helge Holm-Larsen as chair.
In 2025, UV Clinical A/S reported a gross profit of DKK 1,274,253.
UV Clinical A/S had 3 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 20203005, new email: [email protected], new website: www.uvclinical.com (August 24, 2026).
Contact info changed: new phone: 20203005, new email: [email protected], new website: www.uvclinical.com (August 24, 2026).
As of August 19, 2026, Ulstrup Invest ApS is registered as an owner of UV Clinical A/S with an ownership share of 15%.
As of August 19, 2026, Holafa ApS is registered as an owner of UV Clinical A/S with an ownership share of 5%.
UV Clinical A/S has published its annual report for 2025. Gross profit came to DKK 1,274,253, and the net result was DKK -1,282,165.
Contact info changed: new phone: 20203005, new email: [email protected], new website: www.uvclinical.com (May 27, 2026).
Contact info changed: new phone: 20203005, new email: [email protected], new website: www.uvclinical.com (April 28, 2026).
Contact info changed: new phone: 20203005, new email: [email protected], new website: www.uvclinical.com (April 27, 2026).
As of April 27, 2026, Jimmy Bak has left the board of directors of UV Clinical A/S.
Contact info changed: new phone: 20203005, new email: [email protected], new website: www.uvclinical.com (April 9, 2026).
Contact info changed: new phone: 20203005, new email: [email protected], new website: www.uvclinical.com (January 16, 2026).
UV Clinical A/S has published its annual report for 2024. Gross profit came to DKK 392,414, and the net result was DKK -1,895,100.
As of February 21, 2025, Canajo Invest ApS is registered as an owner of UV Clinical A/S with an ownership share of 25%.
UV Clinical A/S has published its annual report for 2023. Gross profit came to DKK 2,235,490, and the net result was DKK -417,179.
UV Clinical A/S has published its annual report for 2022. Gross profit came to DKK 150,952, and the net result was DKK -268,887.
As of October 5, 2022, Emilio de la Guardia Gascuñana has joined the board of directors of UV Clinical A/S.
As of August 23, 2022, Jimmy Bak has joined the board of directors of UV Clinical A/S.
On August 23, 2022, the company changed its name from UV Clinical ApS to UV Clinical A/S.
As of July 5, 2022, Claus Frisenberg Pedersen has left the board of directors of UV Clinical A/S.
UV Clinical A/S has published its annual report for 2021. Gross profit came to DKK 33,464, and the net result was DKK 2,248,332.
As of March 25, 2022, Carsten Viftrup Andersen has left the board of directors of UV Clinical A/S.
As of December 22, 2021, Carsten Viftrup Andersen has joined the board of directors of UV Clinical A/S.
As of November 22, 2021, Claus Frisenberg Pedersen has joined the board of directors of UV Clinical A/S.
As of September 6, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of UV Clinical A/S.
As of September 6, 2021, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of UV Clinical A/S.
As of September 6, 2021, Helge Holm-Larsen has joined the board of directors of UV Clinical A/S.
As of August 2, 2021, Rolf Henrik Sprunk-Jansen is registered as director of UV Clinical A/S.
As of August 2, 2021, Jimmy Bak has stepped down as director of UV Clinical A/S.
As of July 12, 2021, Helge Holm-Larsen has left the board of directors of UV Clinical A/S.
As of July 9, 2021, Rolf Henrik Sprunk-Jansen has joined the board of directors of UV Clinical A/S.
As of July 9, 2021, Jan Friis Schack has left the board of directors of UV Clinical A/S.
As of July 9, 2021, Jimmy Bak has left the board of directors of UV Clinical A/S.
As of July 9, 2021, Gitte Jürgens has stepped down as adm. dir. of UV Clinical A/S.
UV Clinical A/S has published its annual report for 2020. Gross profit came to DKK -411,403, and the net result was DKK -1,149,248.
As of October 5, 2020, Gitte Jürgens is registered as adm. dir. of UV Clinical A/S.
As of September 15, 2020, Jimmy Bak is registered as director of UV Clinical A/S.
As of September 15, 2020, Leif Helth Jensen has stepped down as director of UV Clinical A/S.
UV Clinical A/S has published its annual report for 2019. Gross profit came to DKK -576,665, and the net result was DKK -1,433,657.
As of July 14, 2020, Jan Friis Schack has joined the board of directors of UV Clinical A/S.
As of July 14, 2020, Brian Schebye has left the board of directors of UV Clinical A/S.
As of March 31, 2020, Leif Helth Jensen has left the board of directors of UV Clinical A/S.
As of November 1, 2019, Brian Schebye has joined the board of directors of UV Clinical A/S.
UV Clinical A/S has published its annual report for 2018. Gross profit came to DKK 3,701, and the net result was DKK -798,697.
UV Clinical A/S has published its annual report for 2017. Gross profit came to DKK -376,405, and the net result was DKK -1,115,384.
As of February 27, 2018, Helge Holm-Larsen has joined the board of directors of UV Clinical A/S.
As of February 27, 2018, Anne Sophie Winther Hansen has left the board of directors of UV Clinical A/S.
As of August 21, 2017, Anne Sophie Winther Hansen has joined the board of directors of UV Clinical A/S.
As of August 21, 2017, Gustaf Iuel-Brockdorff has left the board of directors of UV Clinical A/S.
As of February 10, 2017, Jimmy Bak has joined the board of directors of UV Clinical A/S.
As of February 1, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of UV Clinical A/S.
As of February 1, 2017, Gustaf Iuel-Brockdorff has joined the board of directors of UV Clinical A/S.
As of February 1, 2017, Leif Helth Jensen has joined the board of directors of UV Clinical A/S.
As of February 1, 2017, Leif Helth Jensen is registered as director of UV Clinical A/S.
UV Clinical A/S was founded on February 1, 2017.
Companies in the same industry and area
CVR 35806555
CVR 36949740
CVR 38729888
CVR 55730156
CVR 38818791
